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Development, optimization, standardization
and validation of a simple in-house agar
gradient method to determine vancomycin
MIC’s for Staphylococcus aureus
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Background:MIC determination has became easier, with intro-
duction of the E-test. The point of contention has been the cost of
the commercial strips which has restricted its use in resource lim-
ited countries. We attempted to develop, standardize and validate
a simple in – house agar gradient method, to determine MIC of
vancomycin for clinical isolates of S. aureus.
Methods & Materials: In – house strips were made from What-
mann ﬁlter paper no 1. The strips were impregnated with varying
concentration of vancomycin solution so as to create an increas-
ing antibiotic gradient along the strip. During the standardization
step, MIC’s of 90 clinical strains of S. aureus and ATCC 29213 were
tested by the broth microdilution and commercial strip followed
by the in – house strip. The results were kept blinded during the
development stage. Variables for the preliminary considerations
for optimization and standardization of the In – House Agar Gradi-
ent strip were considered to correct the outliers. This was followed
by validation stage where MIC’s of 90 different clinical strains of
S. aureus and ATCC 29213 were determined by the in – house and
results were kept blinded. This was followed by determination of
MIC’s by broth microdilution and commercial strips. An MIC read-
ing of ± 1log2 dilution compared with broth microdilution was
considered as an outlier
Results: During the optimization and standardization stage
there were 7/90 outliers in the clinical strains and no outliers
seen with the ATCC 29213 control strain. Corrective action was
performed by increasing precaution during the antibiotic solution
impregnation stage. During the validation stage, only 4/90 outliers
were observed in the clinical strains. The commercial strips had
29/90 among clinical and 15/30 outliers in the control strain dur-
ing the prevalidation phase. The supplierwas informed tomaintain
cold chain and during the validation phase the outliers for com-
mercial strip were 18/90 and 4/30 in the clinical and control strain
respectively.
Conclusion: Vancomycin sensitivity is reported as MIC. Expen-
sive commercial strips can be replaced by in – house strips using
this simple technique after validating it with a gold standard
method like broth microdilution.
http://dx.doi.org/10.1016/j.ijid.2016.02.285
Type: Poster Presentation
Final Abstract Number: 41.091
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
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Background: Multidrug-resistant (MDR) Gram-negative bacte-
rial pathogens, often resistant to more than one class of antibiotics
including carbapenems and aminoglycosides, pose serious threats
in healthcare settings worldwide. A 2015 White House task force
issued guidelines to combat antibiotic-resistant strains in the
United States, which the Center for Diseases Center has termed
“nightmare bacteria”. MDR pathogens cause at least two million
illnesses and 23,000 deaths annually in the U.S. MDR A. bauman-
nii (MDR-Ab) cause 10% of hospital-acquired infections (HAI) with
70% patient mortality. A mini-outbreak of carbapenem-resistant
(CR)MDR-Ab (CR-MDR-Ab) occurredduringa2009-2010H1N1epi-
demic at CarilionMedical Center (CMC) in Virginia, U.S; three of the
nine patients died. To develop effective strategies for prevention,
control and treatment of MDR infections, we are performing whole
genome analysis of the clinical isolates of CR-MDR-Ab.
Methods & Materials: To date, we have analyzed 68 Ab clini-
cal isolates, including ﬁve CR-MDR-Ab outbreak strains. We have
sequenced and analyzed whole genomes of the following MDR-
Ab isolates: an isolate from outbreak patients (CMC-MDR-Ab4); a
carbapenem-sensitive isolate (CMC-MDR-Ab59); and aCR-MDR-Ab
(CMC-MDR-Ab66) isolate from sporadic cases. The sequencing was
performed on the PacBioRSII platform.
Results: The CR CMC-MDR-Ab strains were found to carry two
plasmids, pCMCVTAb1 and pCMCVTAb2. The latter is conjuga-
tive type and carried two transposons: Tn2008-like, containing a
beta-lactamase gene (blaOXA23) and conferring CR, and a TnaphA6
element causing aminoglycoside resistance and further reducing
treatment choices. Their chromosomes carried ﬁve bla genes and
an aphA1 gene. A PCR analysis based upon the resistant determi-
nants showed that all outbreak isolates (100%) carried pCMCVTAb2
containing the two transposons. Fourteen of the remaining 63
isolates (22.22%) carried pCMCVTAb2 and of these, six (42.85%)
carried Tn2008-like, and two (14.28%) carried TnaphA6. These dif-
ferences are statistically signiﬁcant using Fisher’s exact, two-tailed
p=0.0011, p =0.0445 and p=0.0018.
Conclusion: The results suggested that pCMCVTAb2 was
responsible for the CR-MDR outbreak. A PCR analysis based on the
antibiotic-resistant genes of pCMCVTAb2 could be used for rapid
identiﬁcation of CR-MDR-Ab strains, thereby helping to prevent the
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spread and providing guidance for identiﬁcation and treatment of
hospitalized patients with CR-MDR-Ab infections.
http://dx.doi.org/10.1016/j.ijid.2016.02.286
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Bioﬁlm formation by Staphylococcus species on
exposure of sub-lethal concentration of
vancomycin
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Background: Staphylococcus is responsible for community
acquired andnosocomial infection in different sites of humanbody.
Drug resistant Staphylococcus such asMethicillin resistant Staphy-
lococcus (MRSA) and vancomycin resistant Staphylococcus aureus
(VSRA)hasbecomecommonconcern. Thedrug resistance increases
10 to 1000 foldswhen there is production of bioﬁlm. This study has
assessed level of bioﬁlm production without and on exposure to
sublethal concentration of vancomycin against the clinical isolates
of staphylococcus.
Methods & Materials: A total 103 pure growth of staphylo-
cocci isolated at Department ofMicrobiology, TribhuvanUniversity
Teaching Hospital (TUTH), Kathmandu, was included in the study.
Of them 25 were MSSA, 25 MRSA, 23 MS-CONS and 30 MR-CONS.
All isolateswere subjected for determination ofMIC of vancomycin
by following the standardmethods (Creasten et al andmodiﬁed by
Stepanovic et al,2007)´
Results: Among 103 isolates of Staphylococcus species, many
(97.1%) were found to have MIC of vancomycin within susceptible
range, with few (2.9%) were found to have MIC of intermediate
range. For Staphylococcus aureus 24.0% had MIC level of 2mg/l and
for CONS 45.2% had the MIC level of ≥2mg/l showing high number
of isolates towards upper limit of susceptible range of Methicillin
resistant isolates.
Among the isolates, 63.1% of Staphylococcus species were pro-
ducing different degree of bioﬁlm with CONS sharing the larger
percentage. Sub-lethal concentration of vancomycin has signiﬁ-
cantly (p<0.05) induced bioﬁlm formation in bothMRSA andMSSA,
however, induced effect seems to be higher in MRSA isolates. On
the other hand, in cases of CONS, sub-lethal concentration of van-
comycin could not show signiﬁcant induced effect (p>0.05)
Conclusion: This studyhas concluded that theMIC value of clin-
ical isolates for Staphylococcus is increasing and the sublethal dose
of Vancomycin induces bioﬁlm production and thereby producing
VRSA. Therefore theMIC determination prior to therapy andproper
dosing should be done.
http://dx.doi.org/10.1016/j.ijid.2016.02.287
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Inﬂuence of variation in the sequence(s) of
factors essential for methicillin resistance (fem
genes) on the expression of resistance to
Lysostaphin and secretion of DNAse
R.C. Rosy
Global Medical Education & Research Foundation,
Hyderabad, Telangana, India
Background: In S. aureus, cell wall consists of pentaglycine
bridge which is catalyzed through fem (factors essential for
methicillin resistance) genes namely femX, femA and femB. FemX
adds the 1st glycine, femA adds the 2nd and 3rd glycine and femB
adds the 4th and 5th glycine of the pentaglycine bridge. The target
of the lysostaphin is thepentaglycinecross-bridgebetween3rd&4th
glycine. Mutations in any one of these fem genes, reportedly con-
fer lysostaphin resistance but decreases resistance to beta-lactam
compounds such as methicillin and oxacillin.
Methods & Materials: We screened all Staphylococcus aureus
isolates (n=100) for expression of DNAase and screened 45 isolates
which showed variations in fem gene sequences for the sensitivity
of Lysostaphin. We determined the lysostaphin (20ug) suscepti-
bility through broth dilution method (Hardy’s Test) and DNAse by
both methyl green agar method and also by PCR.
Results: Those S.aureus isolates which failed to amplify any
of the fem genes, considered as total fem mutants displayed 80%
resistance to lysostaphinwhen comparedwithwild isolates.Muta-
tions in femA alone resulted in 70%, 52% (femB) and 52.7% (femX)
resistance to lysostaphin. Fem mutants which showed variable
expression of DNAse were (femA 2%; femB 5%, femX 2%) on DNAse
agar, although all of these isolates were positive for DNAse PCR.
When compared between the species speciﬁc markers ie; nuc gene
and fem (A,B andX genes), nuc gene proved to be reliable for species
identiﬁcation
Conclusion: Lysostaphin cleaves the inter-glycine peptide bond
between the 3rd and 4th glycine and it is expected that any varia-
tion in the fem A or femB gene or fem X may have an impact on the
synthesis of the pentaglycine bridge in the cell wall of S.aureus. Our
results demonstrate that mutations in fem genes not only affect
sensitivity to lysostaphin but also other cell wall functions like
secretion of DNAse.Wewill also present results of analysis of these
fem mutants on expression of PBP2a and the sensitivity to various
antibiotics.
http://dx.doi.org/10.1016/j.ijid.2016.02.288
